Vaccine Safety Conference Company Profile
News Articles
Vaccine Schedule Safe for Kids, Panel Says -- USA Today
Liz Szabo reports on vaccine safety in the US and a study confirming the safety of the CDC’s recommended schedule of inoculations for children. "Parents can have confidence about the safety of the s...
FDA rejects Dynavax's adult hep B vaccine on safety concerns
Feb 25 (Reuters) - U.S. health regulators denied approval to Dynavax Technologies Inc's adult hepatitis B vaccine in its current form and asked for more data to evaluate the vaccine's safety.
Tdap vaccine safe in the elderly: study
NEW YORK (Reuters Health) - The safety profile of tetanus-diphtheria-acellular pertussis (Tdap) vaccine in the elderly mirrors that in younger people, according to new research from the Vaccine Sa...
Phase I/II data on Baxter's Lyme disease candidate vaccine presented at NFID conference
Baxter International Inc. today announced Phase I/II data evaluating the safety and immunogenicity of its investigational Lyme disease candidate vaccine during the National Foundation for Infectious D...
Seasonal flu vaccine safe in early pregnancy, study confirms
NEW YORK (Reuters Health) - A new study provides additional reassurance on the safety of trivalent inactivated influenza vaccine during the first trimester of pregnancy, say researchers with the V...
FDA Turns Down Hep B Vaccine for Now
(MedPage Today) -- The FDA wants more safety data on an investigational adult hepatitis B vaccine before granting approval, the vaccine's manufacturer said Monday.
FDA rejects Dynavax's adult hepatitis B vaccine on safety concerns
(Reuters) - U.S. health regulators denied approval to Dynavax Technologies Inc's adult hepatitis B vaccine in its current form and asked for more data to evaluate the vaccine's safety.
Researchers, policymakers to gather at AIDS Vaccine 2012 conference in Boston
"With a completed trial in Thailand that offered evidence a vaccine could be developed to protect people from HIV, emerging science identifying antibodies against HIV, and a current trial testing a no...
Drugs and Medications
Vivotif-b [Rebel Distributors Corp]
Vivotif-B
Hyperhep b s/d [TALECRIS BIOTHERAPEUTICS, INC.]
Hepatitis B Immune Globulin(Human)HyperHEP B S/DSolvent/Detergent Treated
Nabi-hb [Biotest Pharmaceuticals Corporation]
Hepatitis B Immune Globulin (Human) Nabi-HB Solvent Detergent Treated and Filtered
Nabi-hb [Biotest Pharmaceuticals Corporation]
Hepatitis B Immune Globulin (Human) Nabi-HB Solvent Detergent Treated and Filtered
Hyperrab s/d [TALECRIS BIOTHERAPEUTICS, INC.]
Rabies Immune Globulin (Human)HyperRAB S/DSolvent/Detergent Treated
PubMed Articles
Mode of action of adjuvants: Implications for vaccine safety and design.
For decades, the search for new vaccine adjuvants has been largely empirical. A series of new adjuvants and related formulations are now emerging that are acting through identified immunological mecha...
In 7 large managed care organizations (MCOs), we performed a post-licensure safety assessment of quadrivalent human papillomavirus vaccine (HPV4) among 9-26 year-old female vaccine recipients between...
Vaccine Technology III: An ECI Conference held in Puerto Vallarta, Mexico from June 6-11, 2010.
A non-randomised, open-label, Phase I safety and immunogenicity dose-finding study to assess the safety and immunogenicity of the candidate TB vaccine Modified Vaccinia virus Ankara expressing Antigen...
Conflicts of interest in vaccine safety research.
Conflicts of interest (COIs) cloud vaccine safety research. Sponsors of research have competing interests that may impede the objective study of vaccine side effects. Vaccine manufacturers, health off...
Clinical Trials
Informed Consent in Pediatric Cancer Trials
Background: - Informed consent is the process by which prospective participants in clinical trials learn about clinical research in order to decide whether they want to enroll in...
HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia
A total of 60 participants will be enrolled. They will be in 3 groups 1. ARV-naïve, HIV-positive ≥ 20 year of age with HAD (n=20) who intend to start ARV 2. ARV-naïve, HIV-posit...
This study is aimed at assessing the safety and immunogenicity of different doses and formulations of a new Novartis Meningococcal B Recombinant Vaccine.
Development of a New HIV Vaccine
The purpose of the study is to determine the safety of a new HIV vaccine and to evaluate the immune response to the vaccine. Only some HIV genes are used to make the vaccine and therefore...
Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults
This study will evaluate the safety of and immune response to a new HIV vaccine. The vaccine in this trial uses pieces of HIV DNA and HIV proteins. The vaccine itself cannot cause HIV in...
Companies
GeoVax is a Biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus - AIDS) and other infectious agents. Our goals include: developing AIDS vaccines...
New Mexico Mine Health and Safety Conference
Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen...
More Information about "Vaccine Safety Conference" on BioPortfolio
We have published hundreds of Vaccine Safety Conference news stories on BioPortfolio along with dozens of Vaccine Safety Conference Clinical Trials and PubMed Articles about Vaccine Safety Conference for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vaccine Safety Conference Companies in our database. You can also find out about relevant Vaccine Safety Conference Drugs and Medications on this site too.
